DDR1 activation via cleaved collagen I binding triggered NF-κB-NRF2 signaling to enhance macropinocytosis and mitochondrial biogenesis, fostering tumor progression in pancreatic cancer models [22]. The gene discussed is DDR1; the disease is pancreatic neoplasm.